 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- | SARS-CoV-2 specific antibodies / Distributed Bio
Journal: Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers. (Pubmed Central) - Jun 28, 2021
The modularity of the platform also makes it relevant for rapid evaluation against other infectious diseases of global health importance. Neutralizing antibodies are a promising therapeutic for SARS-CoV-2.